BioNTech dedicated to ship 1.8 billion doses of COVID-19 vaccine this yr By Reuters
© Reuters. FILE PHOTO: Empty vials of the Pfizer-BioNTech coronavirus illness (COVID-19) vaccine are seen at The Michener Institute, in Toronto, Canada January 4, 2021 on this file picture. REUTERS/Carlos Osorio/File Picture
By Ludwig Burger
FRANKFURT (Reuters) – BioNTech mentioned on Monday that its order backlog along with associate Pfizer (NYSE:) for supply of COVID-19 vaccines this yr had grown to 1.8 billion doses, underscoring its position as a serious world provider of immunization photographs.
That was up from 1.4 billion doses introduced in March.
Based mostly on these supply contracts, the agency mentioned it expects about 12.4 billion euros ($15.1 billion) in revenues from the product this yr, together with gross sales, milestone funds from companions and a share of gross revenue within the companions’ territories, up from a earlier projection of 9.8 billion euros.
The companions, which have been spared the kind of manufacturing setbacks that hobbled rivals AstraZeneca (NASDAQ:) and Johnson & Johnson (NYSE:), have repeatedly lifted projected supply volumes amid a world scramble to hurry up vaccination campaigns.
Earlier on Monday, BioNTech unveiled plans to arrange a brand new manufacturing facility in Singapore to provide a number of hundred million doses of its mRNA vaccines per yr from 2023.
BioNTech’s associate for China, Fosun Pharma, mentioned on Sunday it will present a manufacturing facility with an annual capability of as much as 1 billion doses of the COVID-19 vaccine below a three way partnership with BioNTech.
That adopted a contract with the European Union over as much as 1.8 billion doses of COVID-19 vaccines for 2021-2023, to cowl booster photographs, donations and reselling of doses.
BioNTech’s first-quarter complete revenues had been 2.05 billion euros, up from 27.7 million a yr earlier, inflated by the vaccine, and together with an estimated 1.75 billion euros from BioNTech’s share of gross revenue from gross sales in Pfizer’s territories.
Quarterly web revenue jumped to 1.13 billion euros, in comparison with a 53.4-million-euro loss within the year-earlier interval.
The corporate mentioned there was no proof its present vaccine will must be tailored to battle new viral variants however mentioned it had developed methods to handle such variants ought to the necessity come up.
BioNTech reiterated that output capability for the vaccine would attain 3 billion doses by the top of 2021, and greater than 3 billion doses in 2022.
Pfizer final week mentioned the pair was concentrating on manufacturing of as a lot as 4 billion doses of the shot subsequent yr, largely for low- and middle-income nations.
($1 = 0.8222 euros)
Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or harm because of reliance on the knowledge together with information, quotes, charts and purchase/promote alerts contained inside this web site. Please be absolutely knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is among the riskiest funding types attainable.
Hong Kong court delivers guilty verdict in national security law case
Armed police officer escort a van (behind) transporting Tong Ying-kit as he arrives at West Kowloon court in Hong Kong…
U.S.-China rivalry may solidify after Tianjian meeting: CSIS
The rivalry between the U.S. and China is likely to persist for some time after both countries set demands for…